Drugs for Obstructive Airway Diseases
Drugs for Obstructive Airway Diseases Companies (4)
Drugs for Obstructive Airway Diseases News
-
News Drug Approvals from 2025 – Triumphs in the midst of challenges
The following infographic outlines key drugs that have been newly approved by the US FDA in 2025.
Drugs for Obstructive Airway Diseases Products (12)
-
Product VISCOFLU ® nasal Spray
VISCOFLU nasal spray is a medical device made from 3% hypertonic saline solution at controlled pH and 6% N-acetylcysteine. Facilitates the fluidification and mechanical removal of mucusand/or mucopurulent secretions stagnant inside the nasal cavity and inside the paranasal sinuses.anti-mucolytic
-
Product Acetylcysteine Sachet 100mg, 200mg, 600mg
RLD used is Fluimucil (Zambon) and it is developed for Philippines. Product is open for outlicensing for Emerging countries.
-
Product MONTELUKAST
Montelukast is a daily oral medication used to prevent asthma attacks, exercise-induced bronchoconstriction, and allergy symptoms in adults
-
Product TIOTROPIUM DRY POWDER INHALER
18 Mug capsules dry powder inhaler | Therapeutic use: Chronic obstructive pulmonary disease (COPD) | ATC: R03BB04
-
Product VISCOFLU® sachets
VISCOFLU sachets Systemic treatment of respiratory tract diseases characterized by thick and viscous mucosal hypersecretion.
For:
Fluidifies airways secretions.
Decongests mucosa and reduces inflammation.
Supports mucociliary clearance.
Supports the immune system.
-
Product GLYCOPYRRONIUM + INDACATEROL
50 µg + 110 µg capsules dry powder inhaler | Therapeutic use: Chronic obstructive pulmonary disease (COPD) | ATC: R03AL04
-
Product TIOTROPIUM BROMIDE SOFT MIST INHALER
1.25 µg (Asthma)/ 2.5 µg (COPD) soft mist inhaler | Therapeutic use: Asthma/ Chronic obstructive pulmonary disease (COPD) | ATC: R03BB04
-
Product 6% SALINE SOLUTION
6% saline solution at a glance • For inhalation in cases of bronchitis and bronchiolitis • No preservatives • Suitable for use from infancy onwards
-
Product 0.9% SALINE SOLUTION INHALATION PÄDIA
Increases the mobilisation of secretions in the lower respiratory tract in patients with persistent mucus accumulation (acute bronchiolitis, acute obstructive bronchitis and cystic fibrosis) by osmotic effects.
-
Product 3% SALINE SOLUTION
3% saline solution at a glance
• For inhalation in cases of bronchitis and bronchiolitis • No preservatives • Suitable for use from infancy onwards
-
Product Budesolv
Marinosolv® – The Enabling Technology Behind BudesolvBudesolv is an innovative aqueous budesonide formulation based on Marinosolv® drug delivery platform, which has the potential to dramatically improve the solubility and bioavailability of poorly water-soluble compounds. This leads to faster therapeu...
-
Product Theophyllinum Tramco, 1.2 mg/ml, solution for infusion
Theophyllinum Tramco belongs to a group of medicines called xanthines, which relax and expand the airways in the lungs, making breathing easier. It is used for symptomatic treatment of breathing problems due to diseases such as asthma, chronic bronchitis, emphysema, and status asthmaticus. It is ad...
Upcoming Events
-
CPHI & PMEC China 2026
Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026 -
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026 -
CPHI Korea 2026
COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026
